TIDMAXS

RNS Number : 6567R

Accsys Technologies PLC

21 November 2012

AIM: AXS

NYSE Euronext Amsterdam: AXS

21 November 2012

ACCSYS TECHNOLOGIES PLC ("Accsys" or "the Company")

INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2012

Click on, or paste the following link into your web browser, to view the associated PDF document.

http://www.rns-pdf.londonstockexchange.com/rns/6567R_1-2012-11-21.pdf

Highlights

-- Revenue increased by 47% to EUR9.1m for the six months ended 30 September 2012 (2011: EUR6.2m) and included EUR553,000 of licence revenue (2011: EUR75,000);

-- First stages of Process Design Package have been delivered to Rhodia following the signing of an Accoya(R) licence in June 2012 enabling the next stages of their engineering planning;

-- Entered into a 50:50 JV with INEOS Technologies in October 2012 to exploit Accsys' intellectual property surrounding Tricoya(R) wood elements acetylation and processes globally;

-- Sales of Medite Tricoya(R) Extreme Durable MDF are increasing steadily since its launch by our joint development partner, Medite at the end of 2011;

-- Gross manufacturing margin increased by 24% to a positive 15% and the Arnhem manufacturing EBITDA margin improved from -36% to -6%;

-- Total of 36 distribution or agency agreements now in place covering most of Europe, Australia, Canada, Chile, China, India, Mexico, Morocco, New Zealand, parts of South-East Asia and the USA;

-- Accoya(R) and Tricoya(R) continued to gain overall market recognition, for example by winning the Supreme Award for Innovation at the annual Timber Expo in the UK;

-- Cash balance of EUR20.7m at 30 September 2012 (EUR24.6m at 31 March 2012), which excludes EUR4m received from INEOS after the period end following their subscription for 24 million new shares in Accsys; and

   --      Decrease in the loss before tax by 14% to EUR5.4m (2011: EUR6.3m). 

Paul Clegg, Chief Executive commented: "We have had a strategically significant past six months, establishing the INEOS joint venture as a catalyst to developing and exploiting the Tricoya(R) technology, whilst continuing to build on our global market position in Accoya(R) in terms of revenue increases, a greater distribution network and progression with the Rhodia licence agreement. Most importantly, we have achieved these milestones whilst increasing revenues and margins within our core Arnhem manufacturing base, maintaining a strong balance sheet and winning industry awards endorsing the quality of our products. We enter the second half of the year with confidence that we have the building blocks in place to achieve our long term objectives of profitability and increased revenues from our technology licensing business model."

There will be a presentation relating to these results at 10:00 GMT on Wednesday 21 November 2012. The presentation will take the form of a web based conference call, details of which are below:

Webcast link:

Click here or copy and paste ALL of the following text into your browser:

http://www.media-server.com/m/p/uh72q86m

Conference call details for participants:

   Participant Telephone Number:  +44 (0)20 7136 2051         UK Toll 

Confirmation Code: 7591485

Participants will have to quote the above code when dialling into the conference.

For further information, please contact:

 
 Accsys Technologies          Paul Clegg, CEO              via Citigate 
  PLC                          Hans Pauli, COO              Dewe Rogerson 
                               Will Rudge, FD 
                              Oliver Cardigan 
                               Christopher Wilkinson      +44 (0)20 7260 
 Numis Securities              Ben Stoop                   1000 
                                                          +44 (0)20 7282 
                                                           2945 
                              Ginny Pulbrook               +44 (0)20 7282 
                               Malcolm Robertson           2867 
 Citigate Dewe Rogerson        Suzanne Bakker              +31 20 575 4023 
 
 
 
 

Accsys Technologies PLC

Chairman's statement

Introduction

I am happy to report we have made excellent progress in all areas and continue towards our objectives of licensing our technology worldwide and achieving profitability.

Revenue increased by 47% compared to last year while gross manufacturing margin increased by 24%, from minus 9% to a positive 15%. The Arnhem manufacturing facility EBITDA improved from -36% to -6% compared to the same period last year.

We have maintained a strong balance sheet with cash of EUR20.7m at 30 September (EUR24.6m at 31 March 2012). A further EUR4m was received from INEOS shortly after the period end following their subscription for 24 million new shares in Accsys at a subscription price of EUR0.17 at the same time as entering a new joint venture with us, as described below.

We have been working closely with Rhodia following the signing of an Accoya(R) licence in June 2012 and are making progress towards the agreement becoming fully effective later in 2013, after which construction of the 63,000m(3) initial plant is expected to commence.

The commercial deployment of Tricoya(R) has also progressed well, with sales of Medite Tricoya(R) Extreme Durable MDF increasing since its launch by our joint development partner, Medite at the end of 2011. We expect this momentum to continue as new product applications are being identified by distributors. In particular, following the formation of Tricoya Technologies Limited, our joint venture ('JV') with INEOS in October 2012, we now expect to accelerate the global deployment of Tricoya(R) .

Accoya(R) and Tricoya(R) continued to gain overall industry recognition in what remains a difficult market place given the economic conditions affecting the building and construction industry. This has been highlighted by recently winning the Supreme Award for Innovation at the annual Timber Expo in the UK and by being approved as a Durable Wood Preservation Product by the Japan Wood Protection Association and resulting in Accoya(R) being amongst a very select group of solid wood products to be recognised.

I was pleased to welcome Will Rudge to the board on 1 October 2012. Will was previously financial controller, working closely with Hans Pauli who previously held the joint roles of CFO and COO. As a result of the many developments summarised above, the operational work load has increased and Will's appointment enables Hans, who remains on the board as COO, to dedicate more time to the operations of the group including the plant in Arnhem.

Outlook

The last six months has proved particularly exciting and I have been delighted to have developed our relationships with Rhodia and INEOS.

The increase in both sales and profitability indicate that our manufacturing plant will achieve positive EBITDA level at approximately 50% of production capacity; a level which we expect to achieve within the next year. This also demonstrates the potential returns a prospective licensee can generate by manufacturing Accoya(R) . I expect Accoya(R) sales growth to continue; albeit the level of growth will be difficult to predict, however, we are well positioned in the event of an upturn in economic conditions.

The JV entered into with INEOS starts a new phase in the development of Tricoya, a product which I am confident will prove revolutionary in the panel products industry. Accsys' intellectual property and experience with acetylated wood complements INEOS's experience and skills in the field of technology development and licensing and I am looking forward to us accelerating the commercialisation of Tricoya(R) globally.

We continue to develop a number of licensing opportunities, which due to the complex nature and investment required, mean the timing of their completion are difficult to predict. I am, however, confident that our Accoya(R) manufacturing business, which has demonstrated revenue and margin growth, will enable us to achieve our long term objective of profitability as well as further global licensing technology revenue.

Gordon Campbell

Chairman

20 November 2012

Accsys Technologies PLC

Chairman's statement

Accoya(R) wood

Revenue from sales of Accoya(R) produced by our Arnhem plant increased by 40% to EUR7.7m in the first half of the year compared to the same six months in the previous year.

11 out of the top 15 geographies recorded revenue growth compared to the first half of last year as well as compared to the second half of last year. This included the UK, the Netherlands and Germany as well as less established geographies which showed significant growth and indicates a trend for continuing growth. While North American sales were disappointing, we have recently received orders relating to more significant manufacturing opportunities and are confident growth will resume.

Sales to Diamond Wood continue to be less than hoped for as it has still not completed its fund-raising. Consequently, sales during the period from them were less than last year. We will continue to work with Diamond Wood and other business partners to ensure that the significant number of opportunities which exist in the South-East Asia region will be developed. We are confident that this remains a key growth market for Accoya(R) .

Sales to Ireland in the second half of the previous financial year included a substantial volume sold to Medite to enable them to build up initial stocks of Medite Tricoya. Future deliveries to Medite are expected to resume in the near future, however due to the minimum volumes required for individual production runs of MDF panels, the timing and quantities are likely to remain difficult to predict.

We have signed additional distribution agreements adding Iceland, Mexico and Turkey to give us a total of 36 distribution or agency agreements covering most of Europe, Australia, Canada, Chile, China, India, Morocco, New Zealand, parts of South-East Asia and the USA.

We have continued to develop new wood species with the first sales of Accoya(R) Alder following its commercial launch at the end of last year. Significant progress has been made in developing Scots pine, a species which we expect will introduce additional end-product offerings, attract interest as a local species for European markets, as well as being an additional sourcing option. During the period we published the Accoya(R) Structural guide and launched an Accoya(R) product for use within structural projects, together which will open up new business opportunities as well as having already generated sales.

Progress with licensing activity

We have been working closely with Solvay-Rhodia ('Rhodia') following the signing of a licence agreement in June. The licence is for the exclusive rights for a 15 year period to produce and sell Accoya(R) within the Council of Europe, save for the Benelux countries, UK and Ireland. The first plant is expected to have an initial capacity of 63,000m(3) .

An outline engineering plan was delivered to Rhodia soon after signature, and more recently the first stages of the Process Design Package have been delivered, which has enabled Rhodia to progress their detailed engineering planning. Further design work continues to progress as planned, including the sharing of a significant amount of technical knowledge.

Our respective sales teams have also been working closely and have developed relationships with our existing and new customers following Rhodia's commissioning of an extensive market assessment programme. Many customers have been encouraged by the expected increased production capacity that the licence will allow. The programme has also assessed the manufacturing, retail, distribution and tolling markets.

The contract is expected to become fully effective in the second half of 2013 following the approval of both Accsys and Rhodia's board of directors.

As described above, Diamond Wood has not yet completed its fund-raising. We understand that Diamond Wood is no longer expecting to be admitted to the junior market of the Malaysian Stock Exchange as they previously reported. However, we understand that plans are being developed to secure the necessary funding to complete the construction of their first Accoya(R) plant in Nanjing, China. We continue to work with Diamond Wood to ensure that additional Accoya(R) sales opportunities are secured prior to construction.

We have continued Research and Development in respect of new species, new applications for our existing products and process developments which we anticipate will result in improved efficiency and capacity of both our plant and that of our licensees.

Tricoya(R) Technologies Limited ('TTL')

In October 2012 we entered into a 50:50 JV with INEOS Industries Holdings Limited to exploit Accsys' intellectual property surrounding Tricoya(R) wood elements acetylation and processes globally. The new company, TTL, will exploit Accsys' Tricoya technology for the use within MDF, particle board and wood plastic composites; a worldwide market estimated at more than EUR60 billion annually.

INEOS will contribute its significant market reach, technology and licensing as well as intellectual property expertise. Accsys has granted TTL the rights to exploit the Tricoya(R) technology. All new and existing licence agreements concerning Tricoya(R) are expected to be transferred to or entered into directly by TTL, including the licence option agreement entered into in April 2012 with a leading MDF and Particle Board manufacturer in Latin America and Accsys' Joint Development Agreement with Medite.

TTL will carry out all activities relating to Tricoya including business development, marketing, further research and product and process development. The cost of these activities, which will be carried out by Accsys and INEOS staff and which were previously to be borne by Accsys, will now be borne by TTL.

TTL's profits will be shared between INEOS and Accsys in a way which reflects each party's interest. This includes a disproportionate profit share reflecting the contribution of Accsys' intellectual property which will create significant value for Accsys.

As mentioned above, Medite has continued to sell Medite Tricoya(R) Extreme Durable MDF since the end of 2011 and has increased the number of distributors and the volume sold as the year has progressed. These ultra-high performance medium density fibre boards with equivalent to class 1 durability, are quickly gaining industry recognition as a major innovative new product, for example, by winning the Supreme Award for Innovation at this year's Timber Expo in Coventry, UK.

We continue to work closely with our licence option holder in Latin America, with on-going activities concerning market evaluation and preliminary production planning in accordance with the agreement. To support the licensing proposition in this region we have continued to file various national patent applications across Latin America.

We expect sales of Medite Tricoya to continue to increase and TTL will work closely with Medite and the Latin American licence option holder to further develop the product and applications while further market testing takes place.

Discussions with a number of other potential new Accoya(R) and Tricoya(R) licensees continue, however, it remains important to note that any resulting agreements may require significant investment by the other party and as such we expect these negotiations will take time to complete.

The benefits

We expect to continue to grow sales and further increase industry acceptance as a result the superior properties of our products.

Accoya(R) and Tricoya(R) both exhibit class leading dimensional stability and durability properties. These properties mean that Accoya(R) is ideal for use in windows, doors, cladding, decking, structural and civil works and much more. Tricoya(R) panel products can be used in wet and humid environments where previously, wood based panel products were not suitable. The number of applications for Tricoya(R) based panels is growing as a greater number of potential uses are identified. These include cladding, window components, facia and soffit panels, wet interiors, including wall linings in swimming pools, bathrooms, wet rooms etc, speciality furniture (lockers, chairs etc), play frames, signages, automotive parts, sound barriers and potentially even sports equipment.

In addition, both Accoya(R) and Tricoya(R) boast superior green credentials. By significantly enhancing the durability and dimensional stability of fast-growing and abundantly available certified wood, our products provide compelling environmental advantages over slow-growing hardwoods (which are often unsustainably sourced), woods treated with toxic chemicals, and non-renewable carbon-intensive materials such as plastics, metals and concrete.

These properties, which result in lower lifetime costs compared to alternative materials, have also enabled Accoya(R) to hold a number of significant certifications, for example, the Cradle to Cradle Gold level certification.

Financial Review

Statement of comprehensive income

Group revenue increased by 47% to EUR9.1m for the six months ended 30 September 2012 (2011: EUR6.2m). Revenue from Accoya(R) (included within manufacturing revenue) increased by 40% to EUR7.7m, reflecting growth achieved in 11 out of 15 of the top geographies. EUR553,000 of licence income was recorded in the period (2011: EUR75,000) representing a licence option payment and revenue generated in the period from the licence with Rhodia.

Gross margin increased from -7% to 20.5% compared to the same period in the previous year. This was driven by the additional licence income and a significant improvement in the gross manufacturing margin which increased by 24% from minus 9% to a positive 15%. This margin is expected to improve further as our production volumes increase.

Other operating costs increased from EUR5.9m to EUR7.2m. The increase is partly attributable to the relative weakening of the Euro compared to the prior year which has impacted the costs incurred by the Windsor and Dallas offices. In addition, the increase is also attributable to non recurring items including legal and intellectual property costs incurred in relation to the agreements described above. Furthermore, an increase in sales and marketing costs in the period was attributable to the earlier timing of certain exhibitions as well as a general increase in activity, including support of both new and existing distributors.

The Group headcount reduced from 97 at 30 September 2011 to 96 at 31 March 2012 and then to 94 at 30 September 2012.

The decrease in the loss before tax by 14% to EUR5.4m (2011: EUR6.3m) can largely be attributed to the improvement in revenue and gross margin.

Cash flow and financial position

At 30 September 2012, the Group held cash balances of EUR20.7m. The EUR3.9m reduction in cash compared to 31 March 2012 is mainly attributable to the reported operating loss together with an increase in working capital of EUR0.3m, purchases of property plant and equipment of EUR0.2m and capitalised development costs of EUR0.4m. These have been offset by a EUR0.8m receipt of research and development tax credits.

After the period end, in addition to INEOS's joint investment programme with Accsys as described above, INEOS Industries Holdings Limited subscribed for 23,529,412 new ordinary shares in Accsys, at a price of EUR0.17 per share resulting in new equity of EUR4,000,000 and representing 5.4% of the issued share capital of Accsys. Accsys also issued a warrant instrument in favour of INEOS, allowing INEOS the opportunity to purchase up to a further 16,468,236 shares at a price of EUR0.21 per share at certain times during the course of the next four years.

Risks and uncertainties

The Group's principal risks and uncertainties are unchanged from those set out in its 2012 Annual Report.

Going concern

These condensed financial statements are prepared on a going concern basis, which assumes that the Group will continue in operational existence for the foreseeable future, which is deemed to be at least 12 months from the date these interim results were approved.

As part of the Group's going concern review, the Directors have reviewed the Group's trading forecasts and working capital requirements for the foreseeable future. These forecasts indicate that, in order to continue as a going concern, the Group is dependent on the achievement of certain operating performance measures relating to the production and sales of Accoya(R) wood from the plant in Arnhem and the collection of on-going working capital items in line with internally agreed budgets.

The Directors have considered the internally agreed budgets and performance measures and believe that appropriate controls and procedures are in place or will be in place to make sure that these are met. The Directors believe, while some uncertainty inherently remains in achieving the budget, in particular in relation to market conditions outside of the Group's control, that there are a sufficient number of alternative actions and measures that can be taken in order to achieve the Group's medium and long term objectives.

Therefore, the Directors believe that the going concern basis is the most appropriate on which to prepare the financial statements.

Paul Clegg

Chief Executive

20 November 2012

The Directors confirm to the best of their knowledge:

-- The condensed financial statements contained in the half year report have been prepared in accordance with IAS 34 "Interim Financial Reporting" as adopted by the EU;

-- The interim results include a fair review of the information required by DTR 4.2.7R being an indication of important events that have occurred during the first six months of the financial year and a description of the principal risks and uncertainties for the remaining six months of the financial year; and

-- The interim Management Report (Narrative) include a fair review of the information required by DTR 4.28R being disclosure of related party transactions and changes therein since the last annual report.

By order of the Board

Angus Dodwell

Company Secretary

20 November 2012

 
                                       Note      Unaudited      Unaudited     Audited 
                                                  6 months       6 months        Year 
                                                     ended          ended       ended 
                                                                                   31 
                                              30 September   30 September       March 
                                                      2012           2011        2012 
                                                   EUR'000        EUR'000     EUR'000 
                                                     Total          Total       Total 
 
 Accoya(R) wood revenue                              7,690          5,517      13,574 
 Licence revenue                                       553             75          75 
 Other revenue                                         840            639       1,353 
------------------------------------  -----  -------------  -------------  ---------- 
 
 Total revenue                          2            9,083          6,231      15,002 
 
 Total cost of sales                               (7,219)        (6,695)    (15,050) 
 
 Gross profit/(loss)                                 1,864          (464)        (48) 
 
 Other operating costs                  3          (7,224)        (5,852)    (12,497) 
 Impairment of licensee receivables     4                -              -     (2,281) 
 
 Loss from operations                              (5,360)        (6,316)    (14,826) 
 
 Finance income                                        107             22         154 
 Finance expense                                     (124)           (33)       (240) 
 
 Loss before taxation                              (5,377)        (6,327)    (14,912) 
 
 Tax (charge)/credit                                 (108)          (252)         536 
 
 Loss for the period                               (5,485)        (6,579)    (14,376) 
                                             -------------  -------------  ---------- 
 
 Gain arising on translation 
  of foreign operations                                 17             23          35 
 
 Total comprehensive loss for 
  the period                                       (5,468)        (6,556)    (14,341) 
                                             =============  =============  ========== 
 
 
 Basic and diluted loss per 
  ordinary share                        5        EUR(0.01)      EUR(0.02)   EUR(0.04) 
 
 

The notes set out on pages 13 to 18 form part of these condensed financial statements.

 
                                          Unaudited   Unaudited     Audited 
                                           6 months    6 months        Year 
                                              ended       ended       ended 
                                            30 Sept     30 Sept    31 March 
                                   Note        2012        2011        2012 
                                            EUR'000     EUR'000     EUR'000 
 
 Non-current assets 
 Intangible assets                            7,814       7,580       7,579 
 Property, plant and equipment      6        24,799      26,251      25,614 
 Available for sale investments     7             -           -           - 
 Deferred tax                                 1,219       1,846       1,522 
 
                                             33,832      35,677      34,715 
                                         ----------  ----------  ---------- 
 Current assets 
 Inventories                                  3,987       5,811       3,120 
 Trade and other receivables                  3,031       7,879       3,576 
 Cash and cash equivalents                   20,731      27,069      24,574 
 Corporation tax                                516           5       1,117 
 
                                             28,265      40,764      32,387 
                                         ----------  ----------  ---------- 
 
 Current liabilities 
 Trade and other payables                   (3,402)     (5,122)     (3,385) 
 Obligation under finance 
  lease                                       (280)       (280)       (264) 
 
                                            (3,682)     (5,402)     (3,649) 
                                         ----------  ----------  ---------- 
 
 Non-current liabilities 
 Obligation under finance 
  lease                                     (1,928)     (1,955)     (1,960) 
 
                                            (1,928)     (1,955)     (1,960) 
                                         ----------  ----------  ---------- 
 
 Net current assets                          24,583      35,362      28,738 
 
 
 
 Total net assets                            56,487      69,084      61,493 
 
 
 Equity and reserves 
 Share capital - Ordinary 
  shares                            8         4,091       4,039       4,040 
 Share premium account                      124,941     124,877     124,887 
 Capital redemption reserve                     148         148         148 
 Warrants reserve                                82          82          82 
 Merger reserve                             106,707     106,707     106,707 
 Retained earnings                        (179,504)   (166,776)   (174,415) 
 Own shares                                    (39)        (25)           - 
 Foreign currency translation 
  reserve                                        61          32          44 
 
 
 Total equity                                56,487      69,084      61,493 
 
 
 

The notes set out on pages 13 to 18 form part of these condensed financial statements.

 
                                                                                        Foreign 
                                                                                        currency 
                    Share                  Capital                                       trans- 
                   capital     Share     redempt-ion   Warrant     Merger      Own       lation    Retained 
                   Ordinary    premium     reserve      reserve    reserve    Shares    reserve     earnings    Total 
                   EUR'000    EUR'000      EUR'000     EUR'000    EUR'000    EUR'000    EUR'000     EUR'000    EUR'000 
 Balance at 
  31 March 
  2011                4,031    124,809           148         82    106,707      (25)           9   (160,387)    75,374 
 
 Total 
  comprehensive 
  loss for the 
  period                  -          -             -          -          -         -          23     (6,579)   (6,556) 
 Share based 
  payments                -          -             -          -          -         -           -         190       190 
 Shares issued            8          -             -          -          -         -           -           -         8 
 Premium on 
  shares issued           -         70             -          -          -         -           -           -        70 
 Share issue 
  costs                   -        (2)             -          -          -         -           -           -       (2) 
 
 Balance at 
   30 Sept 2011 
   (unaudited)        4,039    124,877           148         82    106,707      (25)          32   (166,776)    69,084 
                  =========  =========  ============  =========  =========  ========  ==========  ==========  ======== 
 
 Total 
  comprehensive 
  loss for the 
  period                  -          -             -          -          -         -          12     (7,797)   (7,785) 
 Share based 
  payments                -          -             -          -          -         -           -         158       158 
 Shares issued            1          -             -          -          -        25           -           -        26 
 Premium on 
  shares issued           -          8             -          -          -         -           -           -         8 
 Share issue 
  costs                   -          2             -          -          -         -           -           -         2 
 
 Balance at 
  31 March 
  2012                4,040    124,887           148         82    106,707         -          44   (174,415)    61,493 
                  =========  =========  ============  =========  =========  ========  ==========  ==========  ======== 
 
 Total 
  comprehensive 
  loss for the 
  period                  -          -             -          -          -         -          17     (5,485)   (5,468) 
 Share based 
  payments                -          -             -          -          -         -           -         396       396 
 Shares issued           51          -             -          -          -      (39)           -           -        12 
 Premium on 
  shares issued           -         54             -          -          -         -           -           -        54 
 Share issue              -          -             -          -          -         -           -           -         - 
  costs 
 
 Balance at 
   30 Sept 2012 
   (unaudited)        4,091    124,941           148         82    106,707      (39)          61   (179,504)    56,487 
                  =========  =========  ============  =========  =========  ========  ==========  ==========  ======== 
 
 

The notes set out on pages 13 to 18 form part of these condensed financial statements.

783,283 of the shares issued in the period relate to the vesting of matching shares held in the Employee share scheme under which 28 employees subscribed in August 2011. A further 415,332 shares were issued in the period to the Employee share scheme under which 19 employees subscribed with the ability to receive a matching share after one year, if still employed by the Group.

Own shares represents 3,926,666 issued to an Employee Benefit Trust at nominal value on 6 July 2012.

 
                                                    Unaudited   Unaudited    Audited 
                                                     6 months    6 months   Year End 
                                                      30 Sept     30 Sept   31 March 
                                                         2012        2011       2012 
                                                      EUR'000     EUR'000    EUR'000 
 
 Profit before taxation                               (5,377)     (6,327)   (14,912) 
 Adjustments for: 
 Amortisation of intangible assets                        145         137        280 
 Depreciation of property, plant and equipment            967         898      1,877 
 Finance expense/(income)                                  17          11         86 
 Reversal of impairment of receivables                      -           -      2,281 
 Equity-settled share-based payment expenses              396         190        348 
 
 Cash flows from operating activities before 
  changes in working capital                          (3,852)     (5,091)   (10,040) 
 
 Decrease/(increase) in trade and other 
  receivables                                             549       1,709      3,734 
 Decrease in deferred income                                -           -    (2,550) 
 (Increase)/Decrease in inventories                     (865)       2,609      5,300 
 Decrease in trade and other payables                      23       (966)      (161) 
 
 Net cash absorbed by operating activities 
  before tax                                          (4,145)     (1,739)    (3,717) 
 
 Tax received                                             796           -          - 
 
 Net cash flows from operating activities             (3,349)     (1,739)    (3,717) 
                                                   ==========  ==========  ========= 
 
 Cash flows from investing activities 
 Interest received                                        107          23        154 
 Expenditure on capitalised internal development        (381)       (142)      (283) 
 Purchase of property, plant and equipment              (152)       (723)    (1,065) 
 
 Net cash absorbed by investing activities              (426)       (842)    (1,194) 
                                                   ==========  ==========  ========= 
 
 Cashflows from financing activities 
 Proceeds from sale and lease back                          -       2,236      2,236 
 Finance expenses                                        (17)           -       (12) 
 Interest Paid                                          (124)           -      (173) 
 Proceeds from issue of share capital                      62          78         89 
 Share issue costs                                          -       (267)      (267) 
 
 Net cash from financing activities                      (79)       2,047      1,873 
                                                   ==========  ==========  ========= 
 
 Net decrease in cash and cash equivalents            (3,854)       (534)    (3,038) 
 Effect of exchange differences on restatement 
  of non Euro functional currency                          11          27         36 
 Opening cash and cash equivalents                     24,574      27,576     27,576 
 
 Closing cash and cash equivalents                     20,731      27,069     24,574 
                                                   ==========  ==========  ========= 
 
 

The notes set out on pages 13 to 18 form part of these interim financial statements.

   1.         Accounting policies 

Basis of accounting

The Group's condensed financial statements in these interim results have been prepared in accordance with International Accounting Standard (IAS) 34 "interim financial reporting" as adopted for use in the European Union. The financial information for the six months ended 30 September 2012 and the six months ended 30 September 2011 is unaudited. The comparative financial information for the full year ended 31 March 2012 does not constitute the group's statutory financial statements for that period although it has been derived from the statutory financial statements for the year then ended. A copy of those statutory financial statements has been delivered to the Registrar of Companies. The auditors' report on those accounts was unqualified and did not contain a statement under 498(2) or 498(3) of the Companies Act 2006.

Changes in accounting policies

No new accounting standards, amendments or interpretations have been adopted in the period which have any impact on these condensed financial statements, or are expected to affect the Group's 2013 Annual report. The accounting policies and methods of computation are consistent with those applied in the 31 March 2012 annual financial statements.

Going concern

These condensed financial statements are prepared on a going concern basis, which assumes that the Group will continue in operational existence for the foreseeable future, which is deemed to be at least 12 months from the date these interim results were approved.

As part of the Group's going concern review, the Directors have reviewed the Group's trading forecasts and working capital requirements for the foreseeable future. These forecasts indicate that, in order to continue as a going concern, the Group is dependent on the achievement of certain operating performance measures relating to the production and sales of Accoya(R) wood from the plant in Arnhem and the collection of on-going working capital items in line with internally agreed budgets.

The Directors have considered the internally agreed budgets and performance measures and believe that appropriate controls and procedures are in place or will be in place to make sure that these are met. The Directors believe, while some uncertainty inherently remains in achieving the budget, in particular in relation to market conditions outside of the Group's control, that there are a sufficient number of alternative actions and measures that can be taken in order to achieve the Group's medium and long term objectives.

Therefore, the Directors believe that the going concern basis is the most appropriate on which to prepare the financial statements.

   2.         Segmental reporting 

The Group's business is the development, commercialisation and licensing of proprietary technology for the manufacture of Accoya(R) wood, Tricoya(R) wood elements and related acetylation technologies. Segmental reporting is divided between licensing activities, the manufacturing and sale of Accoya(R) and research and development activities.

 
 Result by Segment:                                      Licensing 
                               ------------------------------------------------------------ 
 
                                   Unaudited       Unaudited                        Audited 
                                    6 months        6 months                           Year 
                                       ended           ended                          Ended 
                                     30 Sept         30 Sept                       31 March 
                                        2012            2011                           2012 
                                     EUR'000         EUR'000                        EUR'000 
 
 Revenue                                 553              75                             75 
 Cost of sales                             -               -                              - 
 
 Gross profit/(loss)                     553              75                             75 
 
 Other operating 
  costs                              (3,758)         (2,672)                        (5,834) 
 Impairment of 
  licensee receivables                     -               -                        (2,281) 
 
 Loss from operations                (3,205)         (2,597)                        (8,040) 
 
 Loss from Operations                (3,205)         (2,597)                        (8,040) 
 Depreciation and 
  amortisation                           173             160                            330 
 EBITDA                              (3,032)         (2,437)                        (7,710) 
-----------------------------  -------------  --------------  ----------------------------- 
                                                       Manufacturing 
                               ------------------------------------------------------------ 
 
 Revenue                               8,530           6,156                         14,927 
 Cost of sales                       (7,219)         (6,695)                       (15,050) 
 
 Gross profit/(loss)                   1,311           (539)                          (123) 
 
 Other operating 
  costs                              (2,747)         (2,495)                        (5,247) 
 
 Loss from operations                (1,436)         (3,034)                        (5,370) 
 
 Loss from Operations                (1,436)         (3,034)                        (5,370) 
 Depreciation and 
  amortisation                           908             841                          1,754 
 EBITDA                                (528)         (2,193)                        (3,616) 
-----------------------------  -------------  --------------  ----------------------------- 
                                                 Research and Development 
                               ------------------------------------------------------------ 
 
 Revenue                                   -               -                              - 
 Cost of sales                             -               -                              - 
 
 Gross profit/(loss)                       -               -                              - 
 
 Other operating 
  costs                                (719)           (685)                        (1,416) 
 
 Loss from operations                  (719)           (685)                        (1,416) 
 
 Loss from Operations                  (719)           (685)                        (1,416) 
 Depreciation and 
  amortisation                            32              36                             74 
 EBITDA                                (687)           (649)                        (1,342) 
-----------------------------  -------------  --------------  ----------------------------- 
                                                           Total 
                               ------------------------------------------------------------ 
 
 Revenue                               9,083           6,231                         15,002 
 Cost of sales                       (7,219)         (6,695)                       (15,050) 
 
 Gross profit/(loss)                   1,864           (464)                           (48) 
 
 Other operating 
  costs                              (7,224)         (5,852)                       (12,497) 
 Impairment of 
  licensee receivables                     -               -                        (2,281) 
 
 Loss from operations                (5,360)         (6,316)                       (14,826) 
 
 Finance income                          107              22                            154 
 Finance expense                       (124)            (33)                          (240) 
 
 
 Loss before taxation                (5,377)         (6,327)                       (14,912) 
 
 
 Loss from Operations                (5,360)         (6,316)                       (14,826) 
 Depreciation and 
  amortisation                         1,113           1,037                          2,158 
 EBITDA                              (4,247)         (5,279)                       (12,668) 
-----------------------------  -------------  --------------  ----------------------------- 
 
 

Analysis of revenue by geographical destination:

 
                 Unaudited   Unaudited    Audited 
                  6 months    6 months       Year 
                     ended       ended      ended 
                   30 Sept     30 Sept   31 March 
                      2012        2011       2012 
                   EUR'000     EUR'000    EUR'000 
 
  Netherlands        3,060       2,521      5,264 
  United 
   Kingdom           1,832       1,098      2,123 
  Germany              845         440      1,011 
  Switzerland          825         447        735 
  North 
   America             487         529      1,006 
  Belgium              349         147        367 
  Norway               344         139        307 
  China                296         402        784 
  India                180         130        231 
  Italy                155          27        147 
  New Zealand          142           -         49 
  Australia            135          46        129 
  France               121           3        121 
  Ireland               94         146      2,442 
  Greece                92          99        174 
  Other                126          57        112 
 
                     9,083       6,231     15,002 
                ==========  ==========  ========= 
 

The segmental assets in the current and previous periods were predominantly held in Europe. Additions to property, plant, equipment and intangible assets in the current and previous periods were predominantly incurred in Europe.

   3.         Other operating costs 

Other operating costs consist of the operating costs, other than the cost of sales, associated with the operation of the plant in Arnhem and the offices in Dallas and Windsor.

 
                                            Unaudited   Unaudited    Audited 
                                             6 months    6 months       Year 
                                                ended       ended      ended 
                                              30 Sept     30 Sept   31 March 
                                                 2012        2011       2012 
                                              EUR'000     EUR'000    EUR'000 
 
 Sales and marketing                            1,559       1,163      2,264 
 Research and development                         719         685      1,416 
 Depreciation and amortisation                  1,113       1,035      2,159 
 Other operating 
  costs                                         1,069       1,153      2,307 
 Administration 
  costs                                         2,764       1,816      4,351 
 
                                                7,224       5,852     12,497 
                                  ===================  ==========  ========= 
 

Administrative costs include costs associated with the Human Resources, IT, Finance, Management, General Office, Business Development and Legal departments.

The Group headcount reduced from 97 at 30 September 2011 to 96 at 31 March 2012 and then to 94 at 30 September 2012.

During the period EUR381,000 of development costs were capitalised and are included within intangible fixed assets (2011:EUR142,000). This includes EUR140,000 in respect of the Accoya(R) licence Process Design Package.

   4.         Exceptional items - Impairment of assets 

A net impairment of EUR2,281,000 recorded in the year ended March 2012 was attributable to Al Rajhi, representing a non-cash impairment of licensee net receivables (consisting of EUR5,402,000 prepaid commission costs net of EUR2,550,000 deferred income) recorded in previous years. The impairment was recorded as uncertainty remains as to whether the licence will proceed.

This was offset by the reversal of a previous impairment of EUR571,000 reflecting money received from Diamond Wood under the licence agreement subsequent to the year-end.

   5.         Loss per share 
 
                                        Unaudited   Unaudited     Audited 
                                         6 months    6 months        Year 
                                            ended       ended       ended 
                                          30 Sept     30 Sept    31 March 
 Basic and diluted loss per share            2012        2011        2012 
 
 Weighted average number of Ordinary 
  shares in issue ('000)                  406,310     403,364     403,657 
 
 Loss for the period (EUR'000)            (5,485)     (6,579)    (14,376) 
 
 Basic and diluted loss per share       EUR(0.01)   EUR(0.02)   EUR(0.04) 
                                       ==========  ==========  ========== 
 
 

Basic and diluted losses per share are based upon the same figures. There are no dilutive share options as these would increase the loss per share.

   6.         Property, plant and equipment 
 
                                 Freehold       Plant          Office 
                                   land      and machinery    equipment    Total 
                                 EUR'000       EUR'000        EUR'000     EUR'000 
 Cost or valuation 
 At 31 March 2011                   6,815           26,108          462    33,385 
 
 Additions                              -              598          124       722 
 Foreign currency translation 
  gain/(loss)                           -                -          (3)       (3) 
 
 At 30 September 2011               6,815           26,706          583    34,104 
 
 Additions                             65              253           30       348 
 Foreign currency translation 
  gain/(loss)                           -                -          (1)       (1) 
 
 At 31 March 2012                   6,880           26,959          612    34,451 
 
 Additions                              -              120           32       152 
 Foreign currency translation 
  gain/(loss)                           -                -            -         - 
 
 At 30 September 2012               6,880           27,079          644    34,603 
                                =========  ===============  ===========  ======== 
 
 Depreciation 
 At 31 March 2011                       -            6,560          398     6,958 
 
 Charge for the period                 18              850           30       898 
 Foreign currency translation 
  gain/(loss)                           -                -          (3)       (3) 
 
 At 30 September 2011                  18            7,410          425     7,853 
 
 Charge for the period                 57              883           44       984 
 Foreign currency translation 
  gain/(loss)                           -                -            -         - 
 
 At 31 March 2012                      75            8,293          469     8,837 
 
 Charge for the period                 56              876           35       967 
 Foreign currency translation 
  gain/(loss)                           -                -            -         - 
 
 At 30 September 2012                 131            9,169          504     9,804 
                                =========  ===============  ===========  ======== 
 
 Net book value 
 At 31 March 2011                   6,815           19,548           64    26,427 
 
 
 At 30 September 2011               6,797           19,296          158    26,251 
 
 
 At 31 March 2012                   6,805           18,666          143    25,614 
 
 
 At 30 September 2012               6,749           17,910          140    24,799 
 
 
 

Agreements were reached in August 2011 for the sale and leaseback of land and the buildings at Arnhem for a total of EUR4m. EUR2.2m was received in the financial year ending 31 March 2012 with the remaining amount to be received within the next financial year. Subject to the terms of the agreement, the buyer has committed to build new storage facilities which will also allow for an improvement in wood handling logistics. The transaction has resulted in a finance lease creditor of EUR2.2m, as at 30 September 2012.

   7.         Available for sale investments 

Accsys Technologies PLC's investment in Diamond Wood of 21,666,734 shares represented a holding of 5.66% (2011: 5.66%) as at 30 September 2012. So far as we are aware, there has been no change in the investment since that date.

The carrying value of the investment is carried at cost less any provision for impairment, rather than at its fair value, as at 30 September 2012 there was no active market for these shares and there was uncertainty over the potential fundraising efforts of Diamond Wood, and as such a reliable fair value could not be calculated.

The Group does not currently have an intention to dispose of its investment in Diamond Wood in the foreseeable future.

The historical cost of the unlisted shares at 30 September 2012 is EUR10m (2011: EUR10m). However, a provision for the impairment of the entire balance of EUR10m continues to be recorded, as at 30 September 2012 the conclusion of Diamond Wood finalising its funding arrangements was still pending. In the event that Diamond Wood completes the fund-raising, the balance may be re-valued.

   8.          Share capital 

On 6 July 2012, the Company issued 3,926,666 new Ordinary shares to an Employee Benefit Trust at nominal value.

On 23 July 2012, the Company issued 415,332 new Ordinary shares for EUR0.15 each pursuant to the Company's Employee Share Scheme. Proceeds of EUR62,000 were received noting that EUR4,000 is held separately in respect of matching shares which will be issued after one year if the employee is still employed by the Group.

On 8 August 2012, the Company issued 783,283 new Ordinary shares in respect of the vesting of matching shares held in the Employee share scheme under which 28 employees subscribed in August 2011.

At 30 September 2012 the Company had 409,141,923 Ordinary shares in issue (31 March 2012: 404,016,642).

   9.          Related party transactions 

There were no related party transactions in the six months ended 30 September 2012 (2011: nil).

   10.        Post balance sheet events 

On 4 October 2012, Accsys entered a joint venture with INEOS to exploit Accsys' intellectual property surrounding its proprietary Tricoya(R) wood elements acetylation technology and processes, which is now expected to lead to the accelerated global deployment of Tricoya(R) . The new company is called Tricoya Technologies Limited ('TTL').

In addition to INEOS's joint investment programme with Accsys into the Tricoya business, INEOS Industries Holdings Limited subscribed for 23,529,412 new ordinary shares in Accsys, at a price of EUR0.17 per share. Admission of these shares onto the London Stock Exchange and Euronext Amsterdam markets took place on 19 October 2012 following receipt by Accsys of subscription monies totalling EUR4,000,000. The new ordinary shares issued to INEOS represent 5.4% of the issued share capital of Accsys. The Company also executed a warrant instrument in favour of INEOS, allowing INEOS the opportunity to purchase up to a further 16,468,236 shares at a price of EUR0.21 per share at certain times during the course of the next four years

Introduction

We have been engaged by the company to review the condensed consolidated set of financial statements in the half-yearly financial report for the six months ended 30 September 2012, which comprises the Consolidated statement of comprehensive income, Consolidated statement of financial position, Consolidated statement of changes in equity and the interim statement of cash flow and related notes. We have read the other information contained in the half-yearly financial report and considered whether it contains any apparent misstatements or material inconsistencies with the information in the condensed set of financial statements.

Directors' responsibilities

The half-yearly financial report is the responsibility of, and has been approved by, the directors. The directors are responsible for preparing the half-yearly financial report in accordance with the AIM and Euronext Amsterdam by NYSE Euronext Rules for Companies which require that the financial information must be presented and prepared in a form consistent with that which will be adopted in the company's annual financial statements.

As disclosed in note 1, the annual financial statements of the group are prepared in accordance with IFRSs as adopted by the European Union. The condensed set of financial statements included in this half-yearly financial report have been prepared in accordance with International Accounting Standard 34, "Interim Financial Reporting", as adopted by the European Union.

Our responsibility

Our responsibility is to express to the company a conclusion on the condensed set of financial statements in the half-yearly financial report based on our review. This report, including the conclusion, has been prepared for and only for the company for the purpose of the AIM and Euronext Amsterdam by NYSE Euronext Rules for Companies and for no other purpose. We do not, in producing this report, accept or assume responsibility for any other purpose or to any other person to whom this report is shown or into whose hands it may come save where expressly agreed by our prior consent in writing.

Scope of review

We conducted our review in accordance with International Standard on Review Engagements (UK and Ireland) 2410, 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity' issued by the Auditing Practices Board for use in the United Kingdom. A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK and Ireland) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

Conclusion

Based on our review, nothing has come to our attention that causes us to believe that the condensed set of financial statements in the half-yearly financial report for the half year ended 30 September 2012 is not prepared, in all material respects, in accordance with International Accounting Standard 34, "Interim Financial Reporting", as adopted by the European Union, the AIM and Euronext Amsterdam by NYSE Euronext Rules for Companies.

PricewaterhouseCoopers LLP

Chartered Accountants

London

20 November 2012

Notes:

a) The maintenance and integrity of the Accsys Technologies PLC website is the responsibility of the directors; the work carried out by the auditors does not involve consideration of these matters and, accordingly, the auditors accept no responsibility for any changes that may have occurred to the interim financial report since it was initially presented on the website.

b) Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

This information is provided by RNS

The company news service from the London Stock Exchange

END

IR LIFIDLILLFIF

Accsys Technologies (LSE:AXS)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Accsys Technologies Charts.
Accsys Technologies (LSE:AXS)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Accsys Technologies Charts.